Guardian | AlgoVigilance

Independent Safety Monitoring

AlgoVigilance Guardian™

Q3 2026

Guardian™ Launching Q3 2026

An independent safety platform. Guardian works for patients, not industry. Conflict-free by design.

Capability Roadmap

Planned Features

Independent third-party safety oversight
Conflict-free safety monitoring
Real-time safety signal detection
Regulatory compliance guidance
Transparent public safety reporting
No financial ties to pharmaceutical sponsors

Access Protocol

Be First to Know

This service is part of our phased roadmap. Our current focus is building AlgoVigilance Community™, which provides the foundation and funding for all platform services.

Join the Community Learn More About Our Mission

Preparing your experience...